University Hospital Zurich's Health Innovation Hub expands portfolio
Summary
Through a multi-stage process with successive decision points, USZ HIH offers selected startups various support packages to accelerate their development during an incubation period, which lasts between 6 months and 4 years. In cases of commercial success, earnings return to the USZ Foundation to finance additional medical innovations for patients, creating a sustainable funding cycle that enhances the impact of every franc donated.During the incubation period, the projects receive feedback from 20-30 internal and external experts offering tailored advice across different areas such as funding, business strategy, regulatory pathways, and beyond before launching their startups. These are projects that should not just end in scientific publications but should also find their way into practice and onto the market to bring tangible benefits to patients, emphasizes the USZ HIH team.Eligible to participate are projects that have a connection to USZ, a clear clinical need, a strong founding team, and a patient-centered solution that ultimately benefits the Swiss patient population and market. Additionally, in order to qualify, applicants first-in-human trials or market access should be planned within the next five years.With around 40 early-stage projects currently being supported, approximately 36 startups join the portfolio each year. The solution provides a painless, sustainable, and patient-friendly alternative for patients depending on injectable peptide drugs.Spirit X Solutions offers a digital mental health application and serves as a modular digital hub for screening, assessment, monitoring and automated triage, facilitating the path of clients from initial symptoms to appropriate mental health care.Interested USZ-affiliated startups can submit their applications anytime here.